Skip to main content
Landing Pages / Profile
Photo of  Bruce Bracken, MD

Bruce Bracken, MD

  • Fellowship in Urologic Oncology : Memorial Hospital for Cancer and Allied Diseases
  • Urology Residency: University of Michigan
  • General Surgery Residency: Winnipeg General Hospital
  • Medical Degree: University of Manitoba
  • Bachelor's Degree: University of Manitoba
Board Certifications & Licenses

American Board of Urology (Certification Date: 1975-02-28)

Contact Information
  • UC Institute Member Seal
Research Interests

Urologic Oncology

Clinical Interests


Lower Urinary Tract Symptoms

Male Genitalia Cancers

Male Urogenital Diseases

Maple Syrup Urine Disease



Penile Cancer

Prostate Cancer

Prostatic Hyperplasia

Prostatic Intraepithelial Neoplasia


Retractile testicle

Scrotal masses


Sertoli Cell Tumor

Sertoli-Leydig Cell Tumor


Spermatic Cyst



Testicular Cancer

Testicular Hydrocele

Testicular Torsion

Undescended Testicle (Cryptorchidism)

Ureteral Cancer

Ureteral Disease

Urethral Cancer

Urinary Bladder Disease

Urination Disorders

Urine Retention

Urogenital Cancers

Urogenital System

Urologic Cancer

Urologic Disease

Peer Reviewed Publications

Oleksowicz, Leslie; Liu, Yin; Bracken, R Bruce; Gaitonde, Krishnanath; Burke, Barbara; Succop, Paul; Levin, Linda; Dong, Zhongyun; Lu, Shan 2012. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate, 72 10, 1140-9

Dong, Zhongyun; Liu, Yin; Scott, Kieran F; Levin, Linda; Gaitonde, Krishnanath; Bracken, R Bruce; Burke, Barbara; Zhai, Qihui Jim; Wang, Jiang; Oleksowicz, Leslie; Lu, Shan 2010. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis, 31 11, 1948-55

Sweets, Thomas; Bracken, R Bruce; Geisler, Eric J; Warnick, Ronald 2009. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative. Urology, 73 3, 681.e7-9

Tripp, Lloyd D; Warm, Joel S; Matthews, Gerald; Chiu, Peter Y; Bracken, R Bruce 2009. On tracking the course of cerebral oxygen saturation and pilot performance during gravity-induced loss of consciousness. Human factors, 51 6, 775-84

Bruskewitz, R; Girman, C J; Fowler, J; Rigby, O F; Sullivan, M; Bracken, R B; Fusilier, H A; Kozlowski, D; Kantor, S D; Johnson, E L; Wang, D Z; Waldstreicher, J 1999. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology, 54 4, 670-8

Roehrborn, C G; Boyle, P; Bergner, D; Gray, T; Gittelman, M; Shown, T; Melman, A; Bracken, R B; deVere White, R; Taylor, A; Wang, D; Waldstreicher, J 1999. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology, 54 4, 662-9

Schellhammer, P F; Mardovin, W; Davis, N S; Bracken, R B; Stephenson, R A 1997. Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976. Seminars in urologic oncology, 15 2, 99-104

Hedden, R J; Husseinzadeh, N; Bracken, R B 1993. Bladder sparing surgery for locally advanced female urethral cancer. The Journal of urology, 150 4, 1135-7

Tricoli, J V; Bracken, R B 1993. ZFY gene expression and retention in human prostate adenocarcinoma. Genes, chromosomes & cancer, 6 2, 65-72

Tricoli, J V; Yao, J L; D'Souza, S A; Bracken, R B 1993. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes, chromosomes & cancer, 8 1, 28-33

Dodd, G D; Kaufman, P N; Bracken, R B 1991. Renal arterial duplex Doppler ultrasound in dogs with urinary obstruction. The Journal of urology, 145 3, 644-6

Douglas, C; Burke, B; Kessler, D L; Cicmanec, J F; Bracken, R B 1990. Microwave: practical cost-effective method for sterilizing urinary catheters in the home. Urology, 35 3, 219-22

Schwartz, B R; Gregg, R V; Kessler, D L; Bracken, R B 1989. Continuous postoperative epidural analgesia in management of postoperative surgical pain. Urology, 34 6, 349-52

Lian C.;Bracken R. 06-01-1991. Urinary catheter sterilization with microwave oven International Urogynecology Journal, 2 2, 94-97

Stoner E.;Bracken R.;Stein E.;Franke K.;Geller J.;Pratt C.;Imperato- McGinley J.;Vaughan E.;Orlic S.;McConnell J.;Wilson J.;Hill L.;Roy J.;Einfeldt S.;Tenover L.;Zeitner M.;Pappas F.;Gregg H. 01-01-1992. The clinical effects of a 5?-reductase inhibitor, finasteride, on benign prostatic hyperplasia Journal of Urology, 147 5, 1298-1302

Shank R.A.;Barnes M.M.;Benz S.A.;Bracken R.B. 01-01-1990. Innovation in urodynamic testing: Report of the first fully computerized work station Neurourology and Urodynamics, 9 2, 155-164

Bracken R.;Johnson D.;Frazier O.;Logothetis C.;Trindade A.;Samuels M. 01-01-1983. The role of surgery following chemotherapy in stage III germ cell naoplasms Journal of Urology, 129 1, 39-43

Guarda L.;Jaffe N.;Bracken R.;Ayala A. 01-01-1982. Chemotherapeutic-induced histologic changes in Wilms' tumors Laboratory Investigation, 46 1,

Samuels M.;Johnson D.;Bracken R. 01-01-1979. Adjuvant chemotherapy in testis cancer International Journal of Radiation Oncology Biology Physics, 5 SUPPL. 1, 48

Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1977. Primary carcinoma of the female urethra Obstetrical and Gynecological Survey, 32 2, 118-119

Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1976. Primary carcinoma of the female urethra Journal of Urology, 116 2, 188-192

Zornoza J.;Bracken R.;Wallace S. 01-01-1976. Radiologic features of adrenal metastases Urology, 8 3, 295-299

Goldstein H.;Medellin H.;Beydoun M.;Wallace S.;Ben-Menachem Y.;Bracken R.;Johnson D. 01-01-1975. Transcatheter embolization of renal cell carcinoma AMER.J.ROENTGENOL., 123 3, 557-562